Infection Control for New York Health Care Professional ‒ 2024 Update ________________________________
Case Study 2: MRSA Mr. B. arrived at the emergency department with a fever, cough, several skin infections, and obvious chest congestion and that he reports has worsened over the past two weeks. He reported that he was a student at the local college, lived in a dorm with a roommate, and was a member of a soccer team. He had not been hospitalized previously, seemed to have no chronic health conditions, and reported he was normally in good health. Upon further discussion, Mr. B. reported that other team members had similar skin infections and had visited the college clinic. Mr. B. was given oxacillin, but his symptoms remain unchanged. Lab work was conducted and within 48 hours a positive culture was returned for MRSA. Questions 1. What initial clues for ICP from Mr. B’s initial report were missed? 2. What precautions should be taken to minimize further spread? 3. What other healthcare partners, facilities, and individuals should be informed to prevent transmission? Discussion The patient arrived with various signs of infection that should have been investigated. Mr. B. initially supplied critical information when he shared his living and recreational proximity in close contact with others who had similar symptoms, so screening was indicated. Of course, the healthcare team would be informed. The college clinic, dorm(s), athletic department, other school teams they may have played, school staff, faculty, family, and friends should be notified of the potential for infection. The community partners should be educated about the steps to follow for identifying early signs of community spread, possible sources of transmission, and controls to contain the chain of infection. Following HIPAA guidelines to maintain patient privacy, the college clinic would be able to contact patients to receive care. The treating facilities would begin transmission precautions to contain further spread, and all appropriate staff would be informed.
The eight core categories are as follows: 1. Leadership Support: Infection prevention programs require visible and tangible support from all levels of the healthcare facility’s leadership. 2. Education and Training of Healthcare Personnel on Infection Prevention: Training should reflect the diver- sity of the workforce and the facility, and should be tailored to meet the needs of healthcare personnel. 3. Patient, Family and Caregiver Education: Include infor- mation about transmission, prevention, and signs and symptoms that prompt reevaluation and notification of the patient’s healthcare provider. 4. Performance Monitoring and Feedback: Measures should be tailored to the care activities and the popula- tion served. 5. Standard Precautions: These apply to all patient care, regardless of the patient’s suspected or confirmed infectious state, and apply to all settings where care is delivered. 6. Transmission-Based Precautions: Implementation may differ depending on the patient care settings (e.g., inpa- tient, outpatient, long-term care), the facility design, type of patient interaction, and adapted to the specific healthcare setting.
7. Temporary invasive Medical Devices for Clinical Man- agement: Early and prompt removal of invasive devices should be part of the plan of care and included in regular assessment. 8. Occupational Health: It is the professional responsibil- ity of all healthcare organizations and individual per- sonnel to ensure adherence to federal, state, and local requirements concerning immunizations; work policies for safety of healthcare personnel; timely reporting of illness by employees to employers when that illness may represent a risk to patients and other healthcare person- nel; and notification to public health authorities when the illness has public health implications or is required to be reported. Multidrug-Resistant Microorganisms Interim Guidance for a Public Health Response to Contain Novel or Targeted Multidrug-Resistant Organisms (MDROs) The CDC’s 2023 Interim Guidance for a Public Health Response to Contain Novel or Targeted Multidrug-Resistant Organisms (MDROs) explains the initial containment strategies for each of the tiers [16]. It was developed with input from state and local health departments and provides general guidance for response strategies for MDRO at the pre-endemic stages to limit transmission. This document includes interprofessional administrative, leadership, community health partnership, and
50
MDNY1026
Powered by FlippingBook